Company · CIK 0000875045 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BIOGEN INC. · BIIB
Insider activity reported against this company. All insider holders · Files at: BIVV. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 SForm 4 → | Aug 5, 4:03 pm EDT | Lloyd MinorDirector | 1,186 | $202.15 | $239,750 | 2,689 | −30.6% | 10b5-1 |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:50 pm EDT | William A HawkinsDirector | 1,505 | — | — | 10,365 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:47 pm EDT | Stephen A SherwinDirector | 1,505 | — | — | 15,193 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:46 pm EDT | Eric K RowinskyDirector | 1,505 | — | — | 25,844 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:44 pm EDT | Jesus B MantasDirector | 1,505 | — | — | 11,263 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:34 pm EDT | Susan LangerDirector | 1,505 | — | — | 6,634 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:32 pm EDT | Monish D PatolawalaDirector | 1,505 | — | — | 5,215 | — | |
| Jun 9, 2026 AMForm 4 → | Jun 11, 5:21 pm EDT | Menelas N PangalosDirector | 3,875 | — | — | 3,875 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:17 pm EDT | Lloyd MinorDirector | 1,505 | — | — | 3,875 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:09 pm EDT | Maria C FreireDirector | 2,005 | — | — | 8,820 | — | |
| Mar 1, 2019 FMForm 4 → | Mar 5, 4:17 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 1,226 | $334.10 | $219,838 | 7,235 | — | plan? |
| Feb 22, 2019 FMForm 4 → | Feb 26, 5:09 pm EST | Susan H AlexanderEVP Chief Legal Officer & Sec. | 12,167 | $156.80 | $1,647,066 | 31,976 | — | plan? |
| Feb 22, 2019 FMForm 4 → | Feb 26, 5:07 pm EST | Alfred SandrockEVP, Chief Medical Officer | 2,402 | $325.33 | $240,419 | 10,409 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 6:10 pm EST | Michel VounatsosChief Executive Officer, Director | 7,609 | $332.87 | $778,916 | 16,574 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 6:08 pm EST | Alfred SandrockEVP, Chief Medical Officer | 1,904 | $332.87 | $195,062 | 9,485 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 6:07 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 2,091 | $332.87 | $214,035 | 7,325 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 5:54 pm EST | Michael D EhlersEVP, Research and Development | 2,434 | $332.87 | $249,320 | 7,777 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 5:53 pm EST | Susan H AlexanderEVP Chief Legal Officer & Sec. | 2,434 | $332.87 | $249,320 | 28,027 | — | plan? |
| Feb 14, 2019 GForm 4 → | Feb 15, 4:21 pm EST | Brian S PosnerDirector | 315 | — | — | 6,895 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 6:33 pm EST | Michel VounatsosChief Executive Officer, Director | 9,521 | $319.43 | $837,545 | 13,645 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 6:29 pm EST | Alfred SandrockEVP, Chief Medical Officer | 7,161 | $319.43 | $804,325 | 8,753 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 6:17 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 3,981 | $319.43 | $293,556 | 6,520 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 6:10 pm EST | Ginger GregoryEVP, Human Resources | 2,387 | $319.43 | $176,006 | 2,244 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 6:07 pm EST | Michael D EhlersEVP, Research and Development | 5,094 | $319.43 | $404,718 | 6,841 | — | plan? |
| Feb 12, 2019 FMForm 4 → | Feb 14, 6:04 pm EST | Susan H AlexanderEVP Chief Legal Officer & Sec. | 4,289 | $319.43 | $326,138 | 27,091 | — | plan? |
| Jan 30, 2019 PForm 4 → | Feb 1, 4:19 pm EST | Alexander J DennerDirector | 62,800 | $327.59 | $20,572,406 | 524,658 | +13.6% | plan? |
| Jan 2, 2019 FMForm 4 → | Jan 4, 4:17 pm EST | Jeffrey D CapelloEVP & Chief Financial Officer | 1,745 | $304.69 | $126,142 | 917 | — | plan? |
| Dec 1, 2018 FMForm 4 → | Dec 4, 8:21 pm EST | Chirfi GuindoEVP Glob. Mkt Acc & Cust Innov | 1,011 | $333.72 | $136,491 | 2,543 | — | plan? |
| Nov 28, 2018 GForm 4 → | Dec 3, 5:21 pm EST | Lynn SchenkDirector | 32 | — | — | 7,877 | — | plan? late |
| Oct 31, 2018 GForm 4 → | Nov 5, 4:15 pm EST | Stephen A SherwinDirector | 850 | — | — | 5,164 | — | plan? late |
| Sep 26, 2018 SForm 4 → | Sep 27, 4:16 pm EDT | Michael D EhlersEVP, Research and Development | 1,000 | $350.00 | $350,000 | 4,281 | −18.9% | plan? |
| Aug 1, 2018 FMForm 4 → | Aug 3, 4:14 pm EDT | Ginger GregoryEVP, Human Resources | 425 | $344.06 | $56,082 | 959 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 6:04 pm EDT | Alexander J DennerDirector | 880 | — | — | 10,909 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:35 pm EDT | Brian S PosnerDirector | 880 | — | — | 7,210 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:33 pm EDT | Robert W PangiaDirector | 880 | — | — | 18,587 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:32 pm EDT | Richard MulliganDirector | 880 | — | — | 10,909 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:31 pm EDT | Nancy LeamingDirector | 880 | — | — | 10,943 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:29 pm EDT | Caroline DorsaDirector | 880 | — | — | 19,052 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:27 pm EDT | Stelios PapadopoulosDirector | 1,450 | — | — | 3,190 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:25 pm EDT | Eric K RowinskyDirector | 880 | — | — | 15,024 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:23 pm EDT | Lynn SchenkDirector | 880 | — | — | 7,909 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 5:21 pm EDT | Stephen A SherwinDirector | 880 | — | — | 6,014 | — | plan? |
| Jun 1, 2018 FMForm 4 → | Jun 5, 4:31 pm EDT | Michael D EhlersEVP, Research and Development | 2,460 | $297.09 | $319,669 | 5,281 | — | plan? |
| May 2, 2018 FMForm 4 → | May 4, 6:09 pm EDT | Michel VounatsosChief Executive Officer, Director | 2,437 | $274.13 | $205,598 | 9,368 | — | plan? |
| Apr 25, 2018 PForm 4 → | Apr 27, 7:48 am EDT | Alexander J DennerDirector | 48,000 | $269.91 | $12,955,680 | 461,858 | +11.6% | plan? |
| Mar 1, 2018 FMForm 4 → | Mar 5, 4:41 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 1,174 | $282.35 | $181,269 | 4,302 | — | plan? |
| Feb 27, 2018 SForm 4 → | Feb 28, 5:39 pm EST | Alfred SandrockEVP, Chief Medical Officer | 259 | $290.83 | $75,325 | 6,553 | −3.80% | plan? |
| Feb 23, 2018 FMForm 4 → | Feb 27, 6:25 pm EST | Alfred SandrockEVP, Chief Medical Officer | 675 | $292.78 | $60,898 | 6,812 | — | plan? |
| Feb 23, 2018 SForm 4 → | Feb 27, 6:25 pm EST | Alfred SandrockEVP, Chief Medical Officer | 908 | $293.44 | $266,444 | 6,553 | −12.2% | plan? |
| Feb 23, 2018 FMForm 4 → | Feb 27, 6:24 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 120 | $292.78 | $8,198 | 4,744 | — | plan? |
| Feb 23, 2018 FMForm 4 → | Feb 27, 6:22 pm EST | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 1,238 | $292.78 | $111,549 | 24,844 | — | plan? |
| Feb 22, 2018 FMForm 4 → | Feb 26, 4:12 pm EST | Alfred SandrockEVP, Chief Medical Officer | 2,362 | $284.81 | $207,057 | 7,461 | — | plan? |
| Feb 22, 2018 FMForm 4 → | Feb 26, 4:11 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 252 | $284.81 | $16,519 | 4,680 | — | plan? |
| Feb 22, 2018 FMForm 4 → | Feb 26, 4:10 pm EST | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 2,362 | $284.81 | $207,057 | 24,368 | — | plan? |
| Feb 20, 2018 SForm 4 → | Feb 21, 4:10 pm EST | Alfred SandrockEVP, Chief Medical Officer | 743 | $292.00 | $216,956 | 6,553 | −10.2% | plan? |
| Feb 15, 2018 SForm 4 → | Feb 20, 8:09 pm EST | Alfred SandrockEVP, Chief Medical Officer | 1,294 | $298.85 | $386,712 | 7,296 | −15.1% | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 20, 4:27 pm EST | Michel VounatsosChief Executive Officer, Director | 7,231 | $299.38 | $561,936 | 8,356 | — | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 20, 4:25 pm EST | Alfred SandrockEVP, Chief Medical Officer | 1,935 | $299.38 | $178,430 | 8,590 | — | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 20, 4:23 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 1,914 | $299.38 | $132,326 | 4,412 | — | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 20, 4:20 pm EST | Michael D EhlersEVP, Research and Development | 2,221 | $299.38 | $152,384 | 4,898 | — | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 20, 4:18 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 217 | $299.38 | $16,765 | 4,544 | — | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 20, 4:17 pm EST | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 2,222 | $299.38 | $152,684 | 23,460 | — | plan? |
| Feb 12, 2018 FMForm 4 → | Feb 14, 6:37 pm EST | Alfred SandrockEVP, Chief Medical Officer | 3,328 | $316.63 | $416,685 | 7,847 | — | plan? |
| Jan 9, 2018 SForm 4 → | Jan 10, 5:28 pm EST | Robert W PangiaDirector | 5,832 | $329.65 | $1,922,519 | 17,707 | −24.8% | plan? |
| Jan 9, 2018 MForm 4 → | Jan 10, 5:28 pm EST | Robert W PangiaDirector | 5,832 | $57.83 | $337,265 | 23,539 | — | plan? |
| Dec 29, 2017 PForm 4 → | Jan 2, 2018, 4:21 pm EST | Michel VounatsosChief Executive Officer, Director | 780 | $320.55 | $250,029 | 4,879 | +19.0% | plan? |
| Dec 1, 2017 AForm 4 → | Dec 5, 4:41 pm EST | Chirfi GuindoEVP Glob. Mkt Acc & Cust Innov | 2,350 | — | — | 2,350 | — | plan? amended |
| Dec 1, 2017 FForm 4 → | Dec 5, 4:36 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 157 | $319.35 | $50,138 | 4,439 | — | plan? |
| Nov 29, 2017 GForm 4 → | Dec 5, 4:29 pm EST | Stephen A SherwinDirector | 850 | — | — | 5,134 | — | plan? late |
| Nov 28, 2017 PForm 4 → | Nov 30, 7:30 am EST | Alexander J DennerDirector | 30,000 | $317.36 | $9,520,800 | 413,858 | +7.82% | plan? |
| Aug 31, 2017 AForm 4 → | Aug 31, 9:45 pm EDT | Alexander J DennerDirector | 933 | $316.56 | $295,350 | 383,858 | — | plan? |
| Aug 1, 2017 AForm 4 → | Aug 3, 4:34 pm EDT | Ginger GregoryEVP, Human Resources | 860 | — | — | 860 | — | plan? |
| Jul 25, 2017 SForm 4 → | Jul 26, 4:22 pm EDT | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 4,974 | $290.01 | $1,442,510 | 22,258 | −18.3% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 20, 5:00 pm EDT | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 7,758 | $285.00 | $2,211,030 | 27,232 | −22.2% | plan? |
| Jun 9, 2017 SForm 4 → | Jun 12, 4:29 pm EDT | Brian S PosnerDirector | 1,084 | $256.31 | $277,840 | 6,330 | −14.6% | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:58 pm EDT | Eric K RowinskyDirector | 1,055 | — | — | 14,144 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:57 pm EDT | Caroline DorsaDirector | 1,055 | — | — | 18,172 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:55 pm EDT | Richard MulliganDirector | 1,055 | — | — | 10,029 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:54 pm EDT | Stephen A SherwinDirector | 1,055 | — | — | 5,984 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:52 pm EDT | Stelios PapadopoulosDirector | 1,740 | — | — | 19,946 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:50 pm EDT | Robert W PangiaDirector | 1,055 | — | — | 17,707 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:49 pm EDT | Nancy LeamingDirector | 1,055 | — | — | 10,063 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:48 pm EDT | Brian S PosnerDirector | 1,055 | — | — | 7,414 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:46 pm EDT | Lynn SchenkDirector | 1,055 | — | — | 7,029 | — | plan? |
| Jun 7, 2017 AForm 4 → | Jun 9, 5:45 pm EDT | Alexander J DennerDirector | 1,055 | — | — | 10,029 | — | plan? |
| Jun 1, 2017 FMForm 4 → | Jun 5, 4:38 pm EDT | Michael D EhlersEVP, Research and Development | 2,006 | $252.38 | $188,528 | 3,616 | — | plan? |
| May 2, 2017 FMForm 4 → | May 4, 4:16 pm EDT | Michel VounatsosChief Executive Officer, Director | 2,300 | $271.34 | $153,036 | 4,099 | — | plan? |
| May 1, 2017 PForm 4 → | May 2, 4:18 pm EDT | Michel VounatsosChief Executive Officer, Director | 1,402 | $271.35 | $380,433 | 2,927 | +91.9% | plan? |
| Apr 27, 2017 PForm 4 → | May 1, 5:47 pm EDT | Alexander J DennerDirector | 73,858 | $278.50 | $20,569,476 | 383,858 | +23.8% | plan? |
| Apr 25, 2017 SForm 4 → | Apr 27, 4:23 pm EDT | Paul J ClancyExecutive VP and CFO | 9,892 | $290.00 | $2,868,680 | 10,813 | −47.8% | plan? |
| Apr 3, 2017 SForm 4 → | Apr 4, 4:18 pm EDT | Alfred SandrockEVP CMO Neuro & Neurodegenerat | 1,981 | $274.08 | $542,952 | 7,060 | −21.9% | plan? |
| Mar 13, 2017 SForm 4 → | Mar 14, 7:32 pm EDT | Paul J ClancyExecutive VP and CFO | 9,891 | $291.55 | $2,883,721 | 20,705 | −32.3% | plan? |
| Mar 1, 2017 AFMForm 4 → | Mar 3, 6:07 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 3,368 | $293.26 | $46,042 | 3,291 | — | plan? |
| Mar 1, 2017 SForm 4 → | Mar 3, 6:02 pm EST | Alfred SandrockEVP CMO Neuro & Neurodegenerat | 973 | $290.07 | $282,238 | 9,041 | −9.72% | plan? |
| Feb 28, 2017 FMForm 4 → | Mar 2, 5:24 pm EST | Paul J ClancyExecutive VP and CFO | 9,834 | $279.35 | $853,135 | 30,596 | — | plan? |
| Feb 28, 2017 FMForm 4 → | Mar 2, 5:22 pm EST | Alfred SandrockEVP CMO Neuro & Neurodegenerat | 7,766 | $278.17 | $829,217 | 10,014 | — | plan? |
| Feb 28, 2017 FMForm 4 → | Mar 2, 5:20 pm EST | Susan H AlexanderEVP, Chief Legal Officer | 7,968 | $278.54 | $670,996 | 34,990 | — | plan? |
| Feb 28, 2017 FMForm 4 → | Mar 2, 5:18 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 770 | $285.23 | $25,386 | 4,505 | — | plan? |
| Feb 28, 2017 FMForm 4 → | Mar 2, 5:16 pm EST | Adriana KaraboutisEVP, Tech, Bus. Sol & Corp Aff | 2,802 | $286.64 | $211,542 | 8,752 | — | plan? |
| Feb 28, 2017 FMForm 4 → | Mar 2, 5:12 pm EST | Kenneth DiPietroEVP Human Resources | 8,152 | $278.66 | $684,399 | 7,177 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 3, 4:14 pm EDT | Michael PariniChief Legal Officer | 7,405 | — | — | 7,405 | — | |
| Jun 9, 2026 MForm 4 → | Jun 11, 5:21 pm EDT | Menelas N PangalosDirector | 2,370 | — | — | 0 | — | |
| Mar 1, 2019 JMForm 4 → | Mar 5, 4:17 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 848 | — | — | 0 | — | |
| Feb 22, 2019 JMForm 4 → | Feb 26, 5:09 pm EST | Susan H AlexanderEVP Chief Legal Officer & Sec. | 8,877 | — | — | 0 | — | |
| Feb 22, 2019 JMForm 4 → | Feb 26, 5:07 pm EST | Alfred SandrockEVP, Chief Medical Officer | 2,482 | — | — | 0 | — | |
| Feb 15, 2019 JMForm 4 → | Feb 20, 6:10 pm EST | Michel VounatsosChief Executive Officer, Director | 8,498 | — | — | 8,504 | — | |
| Feb 15, 2019 JMForm 4 → | Feb 20, 6:08 pm EST | Alfred SandrockEVP, Chief Medical Officer | 2,126 | — | — | 2,128 | — | |
| Feb 15, 2019 JMForm 4 → | Feb 20, 6:07 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 2,336 | — | — | 2,338 | — | |
| Feb 15, 2019 JMForm 4 → | Feb 20, 5:54 pm EST | Michael D EhlersEVP, Research and Development | 2,718 | — | — | 2,724 | — | |
| Feb 15, 2019 JMForm 4 → | Feb 20, 5:53 pm EST | Susan H AlexanderEVP Chief Legal Officer & Sec. | 2,718 | — | — | 2,724 | — | |
| Feb 12, 2019 AJMForm 4 → | Feb 14, 6:33 pm EST | Michel VounatsosChief Executive Officer, Director | 49,674 | — | — | 37,570 | — | |
| Feb 12, 2019 AJMForm 4 → | Feb 14, 6:29 pm EST | Alfred SandrockEVP, Chief Medical Officer | 17,614 | — | — | 5,528 | — | |
| Feb 12, 2019 AJMForm 4 → | Feb 14, 6:17 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 15,379 | — | — | 10,960 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 6:15 pm EST | Robin KramerVP, Chief Accounting Officer | 860 | — | — | 860 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 6:13 pm EST | Daniel KarpEVP, Corporate Development | 6,260 | — | — | 6,260 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 6:11 pm EST | Chirfi GuindoEVP Glob. Mkt Acc & Cust Innov | 10,960 | — | — | 10,960 | — | |
| Feb 12, 2019 AJMForm 4 → | Feb 14, 6:10 pm EST | Ginger GregoryEVP, Human Resources | 9,540 | — | — | 6,890 | — | |
| Feb 12, 2019 AJMForm 4 → | Feb 14, 6:07 pm EST | Michael D EhlersEVP, Research and Development | 18,984 | — | — | 13,460 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 6:05 pm EST | Jeffrey D CapelloEVP & Chief Financial Officer | 12,520 | — | — | 12,520 | — | |
| Feb 12, 2019 AJMForm 4 → | Feb 14, 6:04 pm EST | Susan H AlexanderEVP Chief Legal Officer & Sec. | 14,736 | — | — | 10,020 | — | |
| Jan 2, 2019 JMForm 4 → | Jan 4, 4:17 pm EST | Jeffrey D CapelloEVP & Chief Financial Officer | 2,992 | — | — | 5,988 | — | |
| Dec 3, 2018 AForm 4 → | Dec 6, 4:20 pm EST | Robin KramerVP, Chief Accounting Officer | 795 | — | — | 265 | — | |
| Dec 1, 2018 JMForm 4 → | Dec 4, 8:21 pm EST | Chirfi GuindoEVP Glob. Mkt Acc & Cust Innov | 1,168 | — | — | 2,342 | — | |
| Aug 1, 2018 JMForm 4 → | Aug 3, 4:14 pm EDT | Ginger GregoryEVP, Human Resources | 426 | — | — | 854 | — | |
| Jul 2, 2018 AForm 4 → | Jul 3, 4:21 pm EDT | Daniel KarpEVP, Corporate Development | 1,760 | — | — | 1,760 | — | |
| Jun 1, 2018 JMForm 4 → | Jun 5, 4:31 pm EDT | Michael D EhlersEVP, Research and Development | 2,494 | — | — | 2,502 | — | |
| May 2, 2018 JMForm 4 → | May 4, 6:09 pm EDT | Michel VounatsosChief Executive Officer, Director | 3,244 | — | — | 3,252 | — | |
| Mar 1, 2018 JMForm 4 → | Mar 5, 4:41 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 844 | — | — | 848 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 4:35 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 531 | — | — | 531 | — | |
| Feb 23, 2018 JMForm 4 → | Feb 27, 6:25 pm EST | Alfred SandrockEVP, Chief Medical Officer | 1,062 | — | — | 0 | — | |
| Feb 23, 2018 JMForm 4 → | Feb 27, 6:24 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 208 | — | — | 0 | — | |
| Feb 23, 2018 JMForm 4 → | Feb 27, 6:22 pm EST | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 1,948 | — | — | 0 | — | |
| Feb 22, 2018 JMForm 4 → | Feb 26, 4:12 pm EST | Alfred SandrockEVP, Chief Medical Officer | 2,478 | — | — | 2,482 | — | |
| Feb 22, 2018 JMForm 4 → | Feb 26, 4:11 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 294 | — | — | 302 | — | |
| Feb 22, 2018 JMForm 4 → | Feb 26, 4:10 pm EST | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 2,478 | — | — | 2,482 | — | |
| Feb 15, 2018 JMForm 4 → | Feb 20, 4:27 pm EST | Michel VounatsosChief Executive Officer, Director | 8,498 | — | — | 17,002 | — | |
| Feb 15, 2018 JMForm 4 → | Feb 20, 4:25 pm EST | Alfred SandrockEVP, Chief Medical Officer | 2,126 | — | — | 4,254 | — | |
| Feb 15, 2018 JMForm 4 → | Feb 20, 4:23 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 2,336 | — | — | 4,674 | — | |
| Feb 15, 2018 JMForm 4 → | Feb 20, 4:20 pm EST | Michael D EhlersEVP, Research and Development | 2,718 | — | — | 5,442 | — | |
| Feb 15, 2018 JMForm 4 → | Feb 20, 4:18 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 256 | — | — | 514 | — | |
| Feb 15, 2018 JMForm 4 → | Feb 20, 4:17 pm EST | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 2,718 | — | — | 5,442 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:46 pm EST | Michael D EhlersEVP, Research and Development | 16,575 | — | — | 11,840 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:44 pm EST | Susan H AlexanderEVP Chief Legal Corp Svc & Sec | 14,155 | — | — | 10,110 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:42 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 1,735 | — | — | 1,390 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:41 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 13,260 | — | — | 9,470 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:40 pm EST | Ginger GregoryEVP, Human Resources | 7,955 | — | — | 5,680 | — | |
| Feb 12, 2018 AForm 4 → | Feb 14, 6:38 pm EST | Michel VounatsosChief Executive Officer, Director | 36,320 | — | — | 36,320 | — | |
| Feb 12, 2018 AJMForm 4 → | Feb 14, 6:37 pm EST | Alfred SandrockEVP, Chief Medical Officer | 15,015 | — | — | 3,418 | — | |
| Jan 9, 2018 MForm 4 → | Jan 10, 5:28 pm EST | Robert W PangiaDirector | 5,832 | — | — | 0 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:32 pm EST | Jeffrey D CapelloEVP & Chief Financial Officer | 14,370 | — | — | 5,390 | — | |
| Dec 1, 2017 AForm 4/A → | Jan 8, 2018, 4:31 pm EST | Chirfi GuindoEVP Glob. Mkt Acc & Cust Innov | 3,510 | — | — | 3,510 | — | |
| Dec 1, 2017 AForm 4 → | Dec 5, 4:41 pm EST | Chirfi GuindoEVP Glob. Mkt Acc & Cust Innov | 1,755 | — | — | 1,755 | — | amended |
| Aug 1, 2017 AForm 4 → | Aug 3, 4:34 pm EDT | Ginger GregoryEVP, Human Resources | 1,280 | — | — | 1,280 | — | |
| Jul 3, 2017 AForm 4 → | Jul 5, 7:18 pm EDT | Jean-Paul KressEVP Pres Int'l & Global Hd GTO | 4,660 | — | — | 4,660 | — | |
| Jun 1, 2017 JMForm 4 → | Jun 5, 4:38 pm EDT | Michael D EhlersEVP, Research and Development | 2,494 | — | — | 4,996 | — | |
| May 2, 2017 JMForm 4 → | May 4, 4:16 pm EDT | Michel VounatsosChief Executive Officer, Director | 3,244 | — | — | 6,496 | — | |
| Mar 1, 2017 JMForm 4 → | Mar 3, 6:07 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 844 | — | — | 1,692 | — | |
| Feb 28, 2017 JMForm 4 → | Mar 2, 5:24 pm EST | Paul J ClancyExecutive VP and CFO | 10,915 | — | — | 0 | — | |
| Feb 28, 2017 JMForm 4 → | Mar 2, 5:22 pm EST | Alfred SandrockEVP CMO Neuro & Neurodegenerat | 9,129 | — | — | 0 | — | |
| Feb 28, 2017 JMForm 4 → | Mar 2, 5:20 pm EST | Susan H AlexanderEVP, Chief Legal Officer | 9,356 | — | — | 0 | — | |
| Feb 28, 2017 JMForm 4 → | Mar 2, 5:18 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 1,083 | — | — | 0 | — | |
| Feb 28, 2017 JMForm 4 → | Mar 2, 5:16 pm EST | Adriana KaraboutisEVP, Tech, Bus. Sol & Corp Aff | 4,214 | — | — | 5,392 | — | |
| Feb 28, 2017 JMForm 4 → | Mar 2, 5:12 pm EST | Kenneth DiPietroEVP Human Resources | 9,489 | — | — | 0 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:35 pm EST | Susan H AlexanderEVP, Chief Legal Officer | 8,160 | — | — | 8,160 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:32 pm EST | Alfred SandrockEVP CMO Neuro & Neurodegenerat | 6,380 | — | — | 6,380 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:30 pm EST | Michel VounatsosChief Executive Officer, Director | 25,500 | — | — | 25,500 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:28 pm EST | Paul J ClancyExecutive VP and CFO | 7,650 | — | — | 7,650 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:26 pm EST | Adriana KaraboutisEVP, Tech, Bus. Sol & Corp Aff | 5,100 | — | — | 5,100 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:24 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 770 | — | — | 770 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:22 pm EST | Michael D EhlersEVP, Research and Development | 8,160 | — | — | 8,160 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:19 pm EST | Paul McKenzieEVP Pharmaceutical Oper & Tech | 7,010 | — | — | 7,010 | — | |
| Feb 15, 2017 AForm 4 → | Feb 17, 8:17 pm EST | Kenneth DiPietroEVP Human Resources | 6,380 | — | — | 6,380 | — | |
| Jan 9, 2017 MForm 4 → | Jan 10, 4:15 pm EST | Robert W PangiaDirector | 5,450 | — | — | 0 | — | |
| Oct 1, 2016 JMForm 4 → | Oct 4, 5:02 pm EDT | Adriana KaraboutisEVP, Tech, Bus. Sol & Corp Aff | 4,262 | — | — | 4,266 | — | |
| Sep 22, 2016 MForm 4 → | Sep 26, 4:24 pm EDT | Caroline DorsaDirector | 27,570 | — | — | 0 | — | |
| Jun 2, 2016 JMForm 4 → | Jun 6, 8:48 pm EDT | Adam KoppelEVP, Strategy and Bus. Dev. | 3,612 | — | — | 3,616 | — | |
| Jun 1, 2016 AForm 4 → | Jun 2, 4:44 pm EDT | Michael D EhlersEVP, Research and Development | 7,320 | — | — | 7,320 | — | |
| May 2, 2016 AForm 4 → | May 4, 5:05 pm EDT | Michel VounatsosEVP & Chief Commercial Officer | 9,520 | — | — | 9,520 | — | |
| May 1, 2016 MForm 4 → | May 2, 4:36 pm EDT | Gregory F CovinoVP, Chief Accounting Officer | 348 | — | — | 0 | — | |
| Apr 2, 2016 MForm 4 → | Apr 5, 5:06 pm EDT | Spyridon Artavanis-TsakonasEVP, Chief Scientific Officer | 975 | — | — | 0 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 5:13 pm EST | Paul J ClancyExecutive VP and CFO | 1,728 | — | — | 3,462 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 5:09 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 198 | — | — | 402 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 5:07 pm EST | Spyridon Artavanis-TsakonasSVP, Chief Scientific Officer | 432 | — | — | 868 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 5:05 pm EST | Susan H AlexanderEVP, Chief Legal Officer | 1,898 | — | — | 3,802 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 5:04 pm EST | John CoxEVP Pharmaceutical Oper & Tech | 2,418 | — | — | 4,842 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 5:02 pm EST | Adam KoppelEVP, Strategy and Bus. Dev. | 898 | — | — | 1,802 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 5:01 pm EST | Kenneth DiPietroEVP Human Resources | 1,898 | — | — | 3,802 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 4:59 pm EST | Steven H HoltzmanEVP Corporate Development | 1,728 | — | — | 3,462 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 4:57 pm EST | Adriana KaraboutisEVP, Tech, Bus. Sol & Corp Aff | 1,486 | — | — | 2,974 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 4:52 pm EST | Alfred SandrockEVP CMO Neuro & Neurodegenerat | 1,036 | — | — | 2,074 | — | |
| Feb 23, 2016 JMForm 4 → | Feb 25, 4:51 pm EST | George A ScangosChief Executive Officer, Director | 8,848 | — | — | 17,702 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:14 pm EST | Adriana KaraboutisEVP, Tech, Bus. Sol & Corp Aff | 7,900 | — | — | 7,900 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:13 pm EST | Susan H AlexanderEVP, Chief Legal Officer | 7,270 | — | — | 7,270 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:12 pm EST | Alfred SandrockEVP CMO Neuro & Neurodegenerat | 7,270 | — | — | 7,270 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:12 pm EST | Spyridon Artavanis-TsakonasSVP, Chief Scientific Officer | 6,800 | — | — | 6,800 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:11 pm EST | Kenneth DiPietroEVP Human Resources | 7,900 | — | — | 7,900 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:10 pm EST | Gregory F CovinoVP, Chief Accounting Officer | 870 | — | — | 870 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:09 pm EST | Paul J ClancyExecutive VP and CFO | 11,060 | — | — | 11,060 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:08 pm EST | John CoxEVP Pharmaceutical Oper & Tech | 11,850 | — | — | 11,850 | — | |
| Feb 22, 2016 AForm 4 → | Feb 24, 6:07 pm EST | George A ScangosChief Executive Officer, Director | 40,460 | — | — | 40,460 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2017 JForm 4 → | Feb 1, 5:21 pm EST | Bioverativ Inc.BIVV | 107,975,968 | — | — | 0 | — | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.